a FO (Fenofibrate 145 mg)

Pill with imprint a FO is White, Elliptical/Oval and has been identified as Fenofibrate 145 mg. It is supplied by Teva Pharmaceuticals.

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iib, elevated ldl vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 145 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for a FO

Fenofibrate

Imprint: a FO
Strength: 145 mg
Color: White
Shape: Elliptical/Oval
Availability: Prescription only
Drug Class: Fibric acid derivatives
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: Teva Pharmaceuticals
Inactive Ingredients: titanium dioxide, magnesium silicate, xanthan gum, docusate sodium, sucrose, sodium lauryl sulfate, lactose monohydrate, microcrystalline cellulose, magnesium stearate, hypromelloses, polyvinyl alcohol
Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code	Labeler / Repackager
00093-2060 (Discontinued)	Teva Pharmaceuticals USA, Inc.
00074-6123 (Discontinued)	Abbott Laboratories
68382-0230 (Discontinued)	Zydus Pharmaceuticals (USA) Inc.
54868-5203 (Discontinued)	Physicians Total Care Inc. (repackager)
54569-5750	A-S Medication Solutions, LLC (repackager)
55289-0973	PDRX Pharmaceuticals Inc. (repackager)
49999-0885 (Discontinued)	Lake Erie Medical and Surgical Supply (repackager)
68071-0800	Nucare Pharmaceuticals Inc. (repackager)